Jie Wu
Impact in
- Molecular Biology top 0.5%
- Protein Tyrosine Phosphatases
- Protein Kinase Regulation and GTPase Signaling
- Melanoma and MAPK Pathways
- PI3K/AKT/mTOR signaling in cancer
- Immunology top 2%
- Galectins and Cancer Biology
Papers in
-
- Protein Tyrosine Phosphatases 32
- Protein Kinase Regulation and GTPase Signaling 20
- Melanoma and MAPK Pathways 12
- PI3K/AKT/mTOR signaling in cancer 11
- Oncology 27
- Cytokine Signaling Pathways and Interactions 13
- Co-authors
- Thomas W. Sturgill (15 shared papers)Michael J. Weber (7 shared papers)Paul Dent (3 shared papers)Jess M. Cunnick (9 shared papers)Alan Wolfman (1 shared paper)Tomáš Jelı́nek (1 shared paper)Richard Jove (9 shared papers)Jay F. Dorsey (8 shared papers)
- Journals
- Journal of Biological Chemistry (15 papers)Molecular and Cellular Biology (6 papers)Blood (3 papers)Molecular Cancer Therapeutics (3 papers)FEBS Letters (3 papers)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Jie Wu
125 papers receiving 8.3k citations
Jie Wu's Hit Papers
Peers
Comparison fields: 5 of 151
- Molecular Biology 5.8k
- Immunology 1.4k
- Oncology 1.6k
- Hematology 549
- Toxicology 160
Countries citing papers authored by Jie Wu
This map shows the geographic impact of Jie Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Wu more than expected).
Fields of papers citing papers by Jie Wu
This network shows the impact of papers produced by Jie Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Wu. The network helps show where Jie Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jie Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of the EGF-Activated MAP Kinase Signaling Pathway by Adenosine 3′,5′-Monophosphate Hit paper breakdown → | 1993 | 825 |
| 2 | The emerging treatment landscape of targeted therapy in non-small-cell lung cancer Hit paper breakdown → | 2019 | 496 |
| 3 | 1991 | 407 | |
| 4 | 1999 | 248 | |
| 5 | 1992 | 237 | |
| 6 | Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. | 2003 | 237 |
| 7 | 2006 | 236 | |
| 8 | 1999 | 227 | |
| 9 | 2020 | 167 | |
| 10 | 2015 | 167 | |
| 11 | 1995 | 163 | |
| 12 | 1995 | 158 | |
| 13 | 2005 | 155 | |
| 14 | 2004 | 149 | |
| 15 | 2004 | 145 | |
| 16 | 2004 | 140 | |
| 17 | 1998 | 139 | |
| 18 | 1992 | 139 | |
| 19 | 2001 | 139 | |
| 20 | 2002 | 132 |
About Jie Wu
Jie Wu is a scholar working on Molecular Biology, Oncology, Immunology, Pulmonary and Respiratory Medicine and Hematology, having authored 128 papers that have together received 8.5k indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (32 papers), Protein Kinase Regulation and GTPase Signaling (20 papers), Galectins and Cancer Biology (17 papers), Cytokine Signaling Pathways and Interactions (13 papers), Lung Cancer Treatments and Mutations (12 papers), Melanoma and MAPK Pathways (12 papers), Chronic Myeloid Leukemia Treatments (11 papers) and PI3K/AKT/mTOR signaling in cancer (11 papers). The work is most often cited by research in Molecular Biology (5.8k citations), Immunology (1.4k citations), Oncology (1.6k citations), Hematology (549 citations) and Toxicology (160 citations). Jie Wu has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Thomas W. Sturgill, Michael J. Weber, Paul Dent, Jess M. Cunnick, Alan Wolfman, Tomáš Jelı́nek, Richard Jove, Jay F. Dorsey, Saı̈d M. Sebti and Yuan Ren. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology, Blood, Molecular Cancer Therapeutics and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.